• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

Olmutinib

(CAS: 1353550-13-6)

Suppliers of Olmutinib

Company Name Email Tel Country
BOC Sciences [email protected] 1-631-504-6093

Fax: 1-631-614-7828Purity: >98% Brand: BOC Sciences

Price and Availability: USD199/200mg (In stock)

Biochempartner Co., Ltd [email protected] 0086-13720134139; 0086-15971444841 China

Fax: Purity: 98% Brand: Biochempartner

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: Brand:

Price and Availability: USD60/5mg () USD96/10mg ()

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: Brand:

Price and Availability: USD60/5mg () USD96/10mg ()
Quality Control & MSDS Files: HNMR LCMS MSDS

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: Brand:

Price and Availability: USD60/5mg () USD96/10mg ()

Shanghai XingMo Biotechnology Co., Ltd. [email protected] 13524779951 CHINA

Fax: Purity: > 98% Brand: X-MoBio

Price and Availability: USD500/1g (In stock)

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of Olmutinib

Olmutinib (HM71224) is a potent small molecule inhibitor of Bruton's tyrosine kinase (BTK).

Solubility of Olmutinib

Solubility Sources
DMSO: 44mg/ml CHEMSCENE, LLC
DMSO: 44mg/ml MedChemexpress Co., Ltd.

Storage Condition of Olmutinib

Storage Condition Sources
Store in a tightly closed container, in a cool and dry place. MedChemexpress Co., Ltd.

MSDS Information

MSDS Sources
MedChemexpress Co., Ltd.

Quality Control and Spectral Data

QC Reports Sources
[HNMR] [LCMS] MedChemexpress Co., Ltd.

Mechanism and Indications

Signaling Pathways JAK/STAT Signaling Protein Tyrosine Kinase/RTK
Target EGFR
Research Area Inflammation/Immunology Cancer
Indications Rheumatoid Arthritis

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
Olmutinib Hanmi Pharmaceutical Company Limited Rheumatoid Arthritis 2013/1/07 2012/11/01 Phase 1 Clinical
Olmutinib - Not Found
Olmutinib - No Development Reported

Chemical Information

M.Wt Formula CAS No. Synonyms
486.59 C26H26N6O2S 1353550-13-6 HM-71224;HM 71224;HM71224; N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide

Structure Information of Olmutinib

Smiles C=CC(NC1=CC=CC(OC2=C3C(C=CS3)=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=N2)=C1)=O
InChI InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)

Related Products

Other Form Products of Olmutinib

Name CAS Formula Suppliers

Recommended Products in Same Target

Name CAS Formula Suppliers
Ginsenoside Rh2 78214-33-2 C36H62O8 7
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 7
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 6
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 6
AZD-9291 1421373-65-0 C28H33N7O2 18
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 5
WHI-P180 211555-08-7 C16H15N3O3 7
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 7
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 5
BGB-102 807640-87-5 C22H25BrN4O2 5
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 12
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 11
CO-1686 1374640-70-6 C27H28F3N7O3 12
CNX-2006 1375465-09-0 C26H27F4N7O2 10
PD168393 194423-15-9 C17H13BrN4O 13
AG 18 118409-57-7 C10H6N2O2 16
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 11
Chrysophanol 481-74-3 C15H10O4 19
AG-1478 153436-53-4 C16H14ClN3O2 12
Mubritinib 366017-09-6 C25H23F3N4O2 24

Recommended Products in the Same Indication

Name CAS Formula Suppliers
Vidofludimus 717824-30-1 C20H18FNO4 14
R406 (free base) 841290-80-0 C22H23FN6O5 9
R406 841290-81-1 C28H29FN6O8S 8
R788 901119-35-5 C23H26FN6O9P 13
R788 (disodium hexahydrate) 914295-16-2 C23H24FN6Na2O9P 7
Itacitinib 1334298-90-6 C26H23F4N9O 5
PH-797804 586379-66-0 C22H19BrF2N2O3 6
Methotrexate 59-05-2 C20H22N8O5 31
ADL-5859 850173-95-4 C24H29ClN2O3 7
Tofacitinib 477600-75-2 C16H20N6O 14
Mizoribine 50924-49-7 C9H13N3O6 16
MK-0812 624733-88-6 C24H34F3N3O3 7
Tofacitinib (citrate) 540737-29-9 C22H28N6O8 18
IB-MECA 152918-18-8 C18H19IN6O4 12
Rofecoxib 162011-90-7 C17H14O4S 9
Baricitinib 1187594-09-7 C16H17N7O2S 19
Duvelisib 1201438-56-3 C22H17ClN6O 19
AVL-292 1202757-89-8 C22H22FN5O3 19
AVL-292 (benzenesulfonate) 1360053-81-1 C28H28FN5O6S 7
R788(prodrug of R406) 1025687-58-4 C23H24FN6Na2O9P 8

Chemical and Physical Properties

Appearance:Light yellow to yellow Solid Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:

Tags: buy Olmutinib | Olmutinib IC50 | Olmutinib price | Olmutinib cost | Olmutinib solubility | Olmutinib purchase | Olmutinib manufacturer | Olmutinib research buy | Olmutinib order | Olmutinib MSDS | Olmutinib chemical structure | Olmutinib Storage condition | Olmutinib molecular weight | Olmutinib mw | Olmutinib datasheet | Olmutinib supplier | Olmutinib cell line | Olmutinib NMR | Olmutinib MS | Olmutinib IR | Olmutinib solubility | Olmutinib Safe information | Olmutinib Qc and Spectral Information | Olmutinib Clinical Information | Olmutinib Clinical Trial | Olmutinib Route of Synthesis | Olmutinib storage condition | Olmutinib diseases and conditions | Olmutinib flash point | Olmutinib boiling point | Olmutinib melting point | Olmutinib storage condition | Olmutinib brand